Jean‐Marc Ferrero

Real‐life activity of eribulin mesylate among metastatic breast cancer patients in the multicenter national observational ESME program

William Jacot, Pierre-Étienne Heudel, Julien Fraisse et al. · International Journal of Cancer · 2019 · 36 citations

Real‐life Activity, Tumor Biology, Metastatic Breast Cancer +13

Phase II trial evaluating a docetaxel‐capecitabine combination as treatment for hormone‐refractory prostate cancer

Jean‐Marc Ferrero, Emmanuel Chamorey, Stéphane Oudard et al. · Cancer · 2006 · 33 citations · Full text

Weekly paclitaxel, capecitabine, and bevacizumab with maintenance capecitabine and bevacizumab as first‐line therapy for triple‐negative, metastatic, or locally advanced breast cancer: Results from the GINECO A‐TaXel phase 2 study

Jean‐Marc Ferrero, Anne‐Claire Hardy‐Bessard, Olivier Capitain et al. · Cancer · 2016 · 33 citations · Full text

Breast Oncology, Maintenance Capecitabine, Medicine +15

Survival outcomes of metastatic breast cancer patients by germline <i>BRCA1/2</i> status in a large multicenter real‐world database

Audrey Mailliez, Véronique D’Hondt, Amélie Lusque et al. · International Journal of Cancer · 2022 · 10 citations · Full text